GlassScriptPhysician profile
Nicholas F Marko
NPI 1114199791
$23,414.07
in general payments reported to CMS, 2019-2025
18 companies · $3,510 in 2025
The $3,510 reported for 2025 was more than what 77% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $1,696 · 2021: $3,070 · 2022: $2,704 · 2023: $494 · 2024: $792 · 2025: $3,510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,552 · Travel and Lodging: $2,245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,552.31 |
| Travel and Lodging | $2,244.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $10,407.40 | 2019 | |
| Medtronic, INC. | $2,890.56 | 2023-2025 | Mazor X System, Intellis Adaptivestim, Synchromedii |
| Globus Medical, INC. | $2,554.95 | 2021-2025 | Excelsius Gps, Creo 5.5 |
| Stryker Corporation | $2,437.64 | 2019-2024 | Everest Spinal System |
| Medtronic USA, INC. | $1,882.58 | 2019-2020 | |
| Abbott Laboratories | $1,676.29 | 2022-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $676.94 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Si-Bone, INC. | $364.05 | 2020-2025 | |
| Nevro Corp. | $198.60 | 2019-2024 | Senza |
| Cerapedics INC. | $98.99 | 2022 | |
| Microtransponder, INC. | $58.01 | 2025 | |
| Novocure INC. | $49.81 | 2023-2025 | Optune, Optune Gio |
| Pacira Pharmaceuticals Incorporated | $28.23 | 2024 | Zilretta, Iovera, Exparel |
| Lemaitre Vascular, INC. | $26.53 | 2023 | Anastoclip Gc 8cm (Medium) |
| Highridge Medical LLC | $20.77 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aesculap, INC. | $14.56 | 2023 | M.Blue |
| Depuy Synthes Sales INC. | $14.15 | 2024 | Synthecel, Matrixneuro |
| Ossur Americas, INC. | $14.01 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Marko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.